Health Care & Life Sciences » Biotechnology | Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd.
Stock Exchange Australian Stock Exchange
EPS
-
Market Cap
AUD16.95 M
Shares Outstanding
394.26 M
Public Float
-

Profile

Address
100 Albert Road
South Melbourne Victoria (VIC) 3205
Australia
Employees -
Website http://www.prescienttherapeutics.com
Updated 07/08/2019
Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded May 22, 1986 and is headquartered in Perth, Australia.

Financials

View All

Steven B. Engle
Non-Executive Chairman
Steven Yatomi-Clarke
Chief Executive Officer, MD & Director